{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-094705","form_type":"8-K","ticker":"CGTX","cik":"0001455365","company_name":"COGNITION THERAPEUTICS INC","filed_at":"2023-08-24T23:59:59+00:00","discovered_at":"2026-05-14T18:03:33.984546+00:00","generated_at":"2026-06-11T04:05:44.346989+00:00","sec_items":["7.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"low","headline":"Cognition Therapeutics files investor presentation; no material news disclosed","bullets":["Presentation covers general pipeline and Phase 3 preparation; no specific financial or clinical data.","Agenda includes funding approach and commercialization readiness for neurodegenerative disorders.","No earnings, trial results, or corporate action announced in the filing."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-094705","json":"https://secwatch.observer/filing/0001104659-23-094705.json","markdown":"https://secwatch.observer/filing/0001104659-23-094705.md","text":"https://secwatch.observer/filing/0001104659-23-094705.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1455365/000110465923094705/0001104659-23-094705-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1455365/000110465923094705/tm2324678d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-11T04:05:44.346989+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}